CompletedNot Applicable

Efficacy of Radiofrequency Micro Needling for the Treatment of Melasma in Skin of Color.

United States10 participantsStarted 2024-10-01

Plain-language summary

The objective of this study is to test the effectiveness of radiofrequency microneedling (RFMN) as a treatment for melasma. The Investigator hypothesize that RFMN will be an effective treatment for melasma in skin of color patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males or females, at least 18 years of age * Fitzpatrick skin types IV-VI * Clinically diagnosed melasma * No topicals (retinol, vitamin C serum, etc) for 6 weeks before Visit 1 (with exception of sunscreen) Exclusion Criteria: * is currently pregnant or planning to conceive during the study period * is using topical or oral therapy or other treatment for melasma

What they're measuring

Treatment efficacy as determined by change in mMASI scoring of melasma severity post-treatment.

Timeframe: 9 months

Trial details

NCT IDNCT06616311

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Melasma trials